173 related articles for article (PubMed ID: 18560566)
1. Hepatotoxin-induced changes in the adult murine liver promote MYC-induced tumorigenesis.
Beer S; Komatsubara K; Bellovin DI; Kurobe M; Sylvester K; Felsher DW
PLoS One; 2008 Jun; 3(6):e2493. PubMed ID: 18560566
[TBL] [Abstract][Full Text] [Related]
2. Low-level shRNA cytotoxicity can contribute to MYC-induced hepatocellular carcinoma in adult mice.
Beer S; Bellovin DI; Lee JS; Komatsubara K; Wang LS; Koh H; Börner K; Storm TA; Davis CR; Kay MA; Felsher DW; Grimm D
Mol Ther; 2010 Jan; 18(1):161-70. PubMed ID: 19844192
[TBL] [Abstract][Full Text] [Related]
3. Developmental context determines latency of MYC-induced tumorigenesis.
Beer S; Zetterberg A; Ihrie RA; McTaggart RA; Yang Q; Bradon N; Arvanitis C; Attardi LD; Feng S; Ruebner B; Cardiff RD; Felsher DW
PLoS Biol; 2004 Nov; 2(11):e332. PubMed ID: 15455033
[TBL] [Abstract][Full Text] [Related]
4. Effect on the expression of c-met, c-myc and PPAR-alpha in liver and liver tumors from rats chronically exposed to the hepatocarcinogenic peroxisome proliferator WY-14,643.
Miller RT; Glover SE; Stewart WS; Corton JC; Popp JA; Cattley RC
Carcinogenesis; 1996 Jun; 17(6):1337-41. PubMed ID: 8681452
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B virus X (HBx) induces tumorigenicity of hepatic progenitor cells in 3,5-diethoxycarbonyl-1,4-dihydrocollidine-treated HBx transgenic mice.
Wang C; Yang W; Yan HX; Luo T; Zhang J; Tang L; Wu FQ; Zhang HL; Yu LX; Zheng LY; Li YQ; Dong W; He YQ; Liu Q; Zou SS; Lin Y; Hu L; Li Z; Wu MC; Wang HY
Hepatology; 2012 Jan; 55(1):108-20. PubMed ID: 21932402
[TBL] [Abstract][Full Text] [Related]
6.
Kastenhuber ER; Lalazar G; Houlihan SL; Tschaharganeh DF; Baslan T; Chen CC; Requena D; Tian S; Bosbach B; Wilkinson JE; Simon SM; Lowe SW
Proc Natl Acad Sci U S A; 2017 Dec; 114(50):13076-13084. PubMed ID: 29162699
[TBL] [Abstract][Full Text] [Related]
7. Transgenic mouse models in carcinogenesis: interaction of c-myc with transforming growth factor alpha and hepatocyte growth factor in hepatocarcinogenesis.
Thorgeirsson SS; Santoni-Rugiu E
Br J Clin Pharmacol; 1996 Jul; 42(1):43-52. PubMed ID: 8807143
[TBL] [Abstract][Full Text] [Related]
8. Hepatic tumor induction in c-myc mono-transgenic and TGF-alpha/c-myc double-transgenic mice.
Thorgeirsson SS; Santoni-Rugiu E; Davis CD; Snyderwine EG
Arch Toxicol Suppl; 1997; 19():359-66. PubMed ID: 9079223
[TBL] [Abstract][Full Text] [Related]
9. Role of oxidative DNA damage caused by carbon tetrachloride-induced liver injury -- enhancement of MeIQ-induced glutathione S-transferase placental form-positive foci in rats.
Iwai S; Karim R; Kitano M; Sukata T; Min W; Morimura K; Wanibuchi H; Seki S; Fukushima S
Cancer Lett; 2002 May; 179(1):15-24. PubMed ID: 11880177
[TBL] [Abstract][Full Text] [Related]
10. Interaction of c-myc with transforming growth factor alpha and hepatocyte growth factor in hepatocarcinogenesis.
Thorgeirsson SS; Santoni-Rugiu E
Mutat Res; 1997 May; 376(1-2):221-34. PubMed ID: 9202759
[TBL] [Abstract][Full Text] [Related]
11. Expression of myc, fos, and Ha-ras in the livers of furan-treated F344 rats and B6C3F1 mice.
Butterworth BE; Sprankle CS; Goldsworthy SM; Wilson DM; Goldsworthy TL
Mol Carcinog; 1994 Jan; 9(1):24-32. PubMed ID: 8297482
[TBL] [Abstract][Full Text] [Related]
12. Association of c-myc overexpression and hyperproliferation with arsenite-induced malignant transformation.
Chen H; Liu J; Zhao CQ; Diwan BA; Merrick BA; Waalkes MP
Toxicol Appl Pharmacol; 2001 Sep; 175(3):260-8. PubMed ID: 11559025
[TBL] [Abstract][Full Text] [Related]
13. Expression of GCIP in transgenic mice decreases susceptibility to chemical hepatocarcinogenesis.
Ma W; Xia X; Stafford LJ; Yu C; Wang F; LeSage G; Liu M
Oncogene; 2006 Jul; 25(30):4207-16. PubMed ID: 16501603
[TBL] [Abstract][Full Text] [Related]
14. Comparison of murine cirrhosis models induced by hepatotoxin administration and common bile duct ligation.
Chang ML; Yeh CT; Chang PY; Chen JC
World J Gastroenterol; 2005 Jul; 11(27):4167-72. PubMed ID: 16015684
[TBL] [Abstract][Full Text] [Related]
15. Promotion of hepatocarcinogenesis by phenobarbital in c-myc/TGF-alpha transgenic mice.
Sanders S; Thorgeirsson SS
Mol Carcinog; 2000 Jul; 28(3):168-73. PubMed ID: 10942533
[TBL] [Abstract][Full Text] [Related]
16. Transgenic CHD1L expression in mouse induces spontaneous tumors.
Chen M; Huang JD; Hu L; Zheng BJ; Chen L; Tsang SL; Guan XY
PLoS One; 2009 Aug; 4(8):e6727. PubMed ID: 19701453
[TBL] [Abstract][Full Text] [Related]
17. Impact of hydrodynamic injection and phiC31 integrase on tumor latency in a mouse model of MYC-induced hepatocellular carcinoma.
Woodard LE; Keravala A; Jung WE; Wapinski OL; Yang Q; Felsher DW; Calos MP
PLoS One; 2010 Jun; 5(6):e11367. PubMed ID: 20614008
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of c-jun and c-myc in N-nitroso diethylamine-induced hepatic oncogenesis in AKR mice.
Giri RK; Das BR
Cancer Lett; 1996 Dec; 109(1-2):121-7. PubMed ID: 9020911
[TBL] [Abstract][Full Text] [Related]
19. Hypomethylation of ras oncogenes in chemically induced and spontaneous B6C3F1 mouse liver tumors.
Vorce RL; Goodman JI
Mol Toxicol; 1989; 2(2):99-116. PubMed ID: 2702305
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of neoplastic development in the liver by hepatocyte growth factor in a transgenic mouse model.
Santoni-Rugiu E; Preisegger KH; Kiss A; Audolfsson T; Shiota G; Schmidt EV; Thorgeirsson SS
Proc Natl Acad Sci U S A; 1996 Sep; 93(18):9577-82. PubMed ID: 8790372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
